Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infections after hysterectomy – azithromycin + cefuroxime vs cefuroxime
2024-517508-12-00Phase 4Authorised
- Sponsor
- Helsinki University Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in surgical site infection (SSI) comparing Azithromycin + cefuroxime with Cefuroxime + placebo (2 arms). Primary endpoint: Deep wound and pelvic organ infections within 30 days postoperatively. Planned start Oct 2024; status: authorised.
02
Drugs
azithromycincefuroxime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2024-517508-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517508-12-00.